Home/Filings/4/0001213900-22-074722
4//SEC Filing

Jermasek Douglas 4

Accession 0001213900-22-074722

CIK 0001766140other

Filed

Nov 22, 7:00 PM ET

Accepted

Nov 23, 8:00 AM ET

Size

5.3 KB

Accession

0001213900-22-074722

Insider Transaction Report

Form 4
Period: 2022-11-21
Jermasek Douglas
EVP of Corporate Strategy
Transactions
  • Award

    Stock Options

    2022-11-21+55,000155,000 total
    Exercise: $0.75Exp: 2032-11-21Common Stock (55,000 underlying)
Footnotes (1)
  • [F1]13,750 of the stock options vest on first anniversary of the date of grant and 1/36th of the remaining options vest at the end of each successive month thereafter.

Documents

1 file

Issuer

Unicycive Therapeutics, Inc.

CIK 0001766140

Entity typeother

Related Parties

1
  • filerCIK 0001955273

Filing Metadata

Form type
4
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 8:00 AM ET
Size
5.3 KB